Chapel Hill
-
Study finds dozens of associations between genes, diseases in minorities
The researchers at the University of North Carolina who conducted the PAGE study said the results are especially important in the context of precision medicine.
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
Drug to replicate effects of gastric bypass surgery gets AHA backing
About 200,000 people undergo gastric bypass surgery each year and contribute to an estimated $147 […]
-
Health IT, Hospitals, Startups
Emphasis on local investing shifts to Southeast with $5.1M angel fund and accelerators
One of the ongoing debates among investors is whether geography matters. I have often heard […]
-
What can U.S. healthcare innovators learn from medical tourism inside and outside its borders?
Mexico’s beaches are supposed to be beautiful so maybe it’s not hard to understand why […]
-
Devices & Diagnostics, Startups
Applying neuromodulation to acute heart failure nets NC device startup a $13M series A
Neurostimulation devices that send mild electrical pulses to target nerves are arguably the fastest-growing segment […]
-
G1 Therapeutics developing treatment to protect soldiers, chemo patients from radiation damage
After the Boston Marathon bombing, it’s easy to understand why the government is giving G1 […]
-
Heat Biologics gets $5M to usher heat shock protein therapy into phase 2 lung cancer trials
A company developing an off-the-shelf immunotherapy that it thinks can turn tumors into adjuvant-secreting machines […]
-
Improving Communication Between Patients and Providers
Sarah Shillington, Chief Customer Officer notes how Artera’s omnichannel platform works.
-
UNC spinout wants to help health workers wipe out surface contamination by harmful cancer drugs
Chemotherapy drugs used today are potent and nonselective, meaning they kill both cancerous and non-cancerous […]
-
Biopharmaceutical startup developing heart failure therapeutic raises more than $28M
A drug developer with a treatment for acute decompensated heart failure, one of the leading reasons for hospitalization, has raised more than $28 million.
-
A surprising reason why some newborns test positive for marijuana
Some newborns are testing positive for marijuana exposure and the reason why could surprise you. […]
-
Hepatitis C, liver cancer research at UNC secures $2.3M federal grant
The hepatitis C virus is believed to have links to the growth of liver cancer, […]
-
Unlocking university innovation: UNC’s Rose nurtures new life science startups
Don Rose has a front seat to watch many of the emerging life science companies […]
-
Pozen migraine drug licensed to Desitin for commercialization in Europe
The migraine headache treatment developed by Pozen (NASDAQ:POZN) now has a partner for commercialization in […]